AzTrials
AzTrials

Smoking CessationNCT03446183

Short Term Effect of Smoking Cessation on Human Metabolism

An observational study of Smoking Cessation and Metabolic Syndrome, run by Hebrew University of Jerusalem.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Investigating the short term smoking cessation on metabolism, examining of participant of smoking cessation workshops and former participants' file survey for metabolic aspects Read more about this study

Who is it for?
Ages 25 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Smoking Cessation, Metabolic Syndrome
What is being tested?
Smoking cessation workshops
How many people
308 participants
Where
No sites listed yet
Study dates
18 Apr 2016to 1 Sep 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Volunteers who were recruited from the smoking cessation workshops of the Meuhedet HMO (Israeli Health Services) during 2016-2017.

Who may be able to join

  • Volunteers who were recruited from the smoking cessation workshops of the Meuhedet HMO (Israeli Health Services) during 2016-2017.

Who cannot join

  • Candidates with benign tumors, bariatric surgeries, and endoscopic bariatric procedures before or during the study period were excluded

About this study

Investigating the short term smoking cessation on metabolism, examining of participant of smoking cessation workshops and former participants' file survey for metabolic aspects

Read the detailed description

Objective: To examine metabolic aspects occurring during the first 6-12 months following smoking cessation in participants of smoking cessation workshops.

Design: A two armed study: prospective and retrospective. Prospective: Weight, BMI, waist circumference and waist: hip ratio were measured before, during and 6 months post cessation program. Retrospective: Blood test data for Blood fasting glucose (BFG) and lipid profile from the year preceding the workshops and the year after them were analyzed from participants' files. Smoking status was verified by phone conversation.

Being tested
Smoking cessation workshops
Medical subject headings
Smoking Cessation, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smoking cessation workshopsBehavioural

    All the participants took part in smoking cessation workshops. The comparison of metabolic aspects was made between the smokers and non-smokers

Study groups in NCT03446183
Study groupRoleWhat they receive
Smoking cessation prospectiveSmoking cessation workshops
Receives: Behavioral: Smoking cessation workshops
Smoking cessation retrospectiveFile review of former workshop participants
Receives: Behavioral: Smoking cessation workshops

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in weight

    Weight in meters

    Measured: 6 months from baseline

  2. Change in BMI

    BMI in kg/m2

    Measured: 6 months from baseline

  3. Change in waist and hip circumference

    Waist and hip curcumference in centimeters

    Measured: 6 months from baseline

  4. Change in Blood fasting glucose according to patient files (unspecified time points up to a year before and a year after the workshops)

    BFG in mg/dl

    Measured: up to 2 years from baseline

  5. Change in lipid profile according to patient files (unspecified time points up to a year before and a year after the workshops)

    Lipid particle measurements in mg/dl

    Measured: up to 2 years from baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2018
  2. Study start18 Apr 2016
  3. Primary completion1 Sep 2017
  4. Study completion1 Sep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
308 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03446183
Sponsor's protocol ID
smoking cessation
Status last verified
Feb 2018
First submitted
15 Feb 2018
Last updated
26 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This was not a part of Helsinki Committee approval. Anonymization of data for sharing is not expected.

Questions about this trial

What is this clinical trial studying?

An observational study of Smoking Cessation and Metabolic Syndrome, run by Hebrew University of Jerusalem.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in weight (time frame: 6 months from baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in